* Veracyte Inc VCYT.OQ reported a quarterly adjusted loss
of 20
cents per share for the quarter ended in March. The mean
expectation of ten analysts for the quarter was for a loss of 24
cents per share.
* Revenue rose 84.7% to $67.78 million from a year ago;
analysts
expected $62.32 million.
* Veracyte Inc's reported EPS for the quarter was a loss
of 20
cents.
* The mean earnings estimate of analysts had fallen by
about 41.1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Veracyte Inc shares had fallen by 21.7% this quarter and
lost 47.6% so far this year.
* The company reported a quarterly loss of $14.46 million.
* Wall Street's median 12-month price target for Veracyte
Inc is
$37.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated May 4 at 03:08 a.m. All
figures in US dollars unless otherwise stated